Baughman RP, Teirstein AS, Judson MA, et al. Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med. 2001;164:1885–9.

Article  CAS  PubMed  Google Scholar 

Drafting Committee for Hepatitis Management Guidelines, the Japan Society of Hatology. Japan Society of Hepatology guidelines for the management of hepatitis B virus infection: 2019 update. Hepatol Res. 2019;2020(50):892–923.

Google Scholar 

Fouts DW, Byrne EB, Israel HL. Hepatitis-associated antigen and sarcoidosis. Lancet. 1970;2:1257.

Article  CAS  PubMed  Google Scholar 

Kawaguchi K, Miyake S, Sugiyama A. A case of sarcoidosis complicated by chronic hepatitis B. Kanzou. 1988;29:77–80.

Article  Google Scholar 

Patel S, Patel P, Jiyani R, et al. A rare case of hepatic sarcoidosis caused by hepatitis B virus and treatment-induced opportunistic infection. Cureus. 2020;12: e10454.

PubMed  PubMed Central  Google Scholar 

Ayyala US, Padilla ML. Diagnosis and treatment of hepatic sarcoidosis. Curr Treat Options Gastroenterol. 2006;9:475–83.

Article  PubMed  Google Scholar 

Judson MA. Hepatic, splenic, and gastrointestinal involvement with sarcoidosis. Semin Respir Crit Care Med. 2002;23:529–41.

Article  PubMed  Google Scholar 

Rømer FK. Presentation of sarcoidosis and outcome of pulmonary changes. Dan Med Bull. 1982;29:27–32.

PubMed  Google Scholar 

Chappell AG, Cheung WY, Hutchings HA. Sarcoidosis: a long-term follow up study. Sarcoidosis Vasc Diffuse Lung Dis. 2000;17:167–73.

CAS  PubMed  Google Scholar 

Mañá J, Salazar A, Manresa F. Clinical factors predicting persistence of activity in sarcoidosis: a multivariate analysis of 193 cases. Respiration. 1994;61:219–25.

Article  PubMed  Google Scholar 

Belperio JA, Shaikh F, Abtin FG, et al. Diagnosis and treatment of pulmonary sarcoidosis: a review. JAMA. 2022;327:856–67.

Article  CAS  PubMed  Google Scholar 

Kable T, DuMontier S, Streiler C. Sarcoidosis: a review of the guidelines and what’s to come. Mo Med. 2024;121:373–8.

PubMed  PubMed Central  Google Scholar 

Kikuchi M, Koizumi A, Namisaki T, et al. Improvement of liver histology in hepatic sarcoidosis due to treatment with corticosteroids and ursodeoxycholic acid: a case report. Clin J Gastroenterol. 2024;17:327–33.

Article  PubMed  Google Scholar 

Zhang H, Costabel U, Dai H. The role of diverse immune cells in sarcoidosis. Front Immunol. 2021;12: 788502.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Masuda M, Arai Y, Okamura T, et al. Pure red cell aplasia with thymona: evidence of T-cell clonal disorder. Am J Hematol. 1997;54:324–8.

Article  CAS  PubMed  Google Scholar 

Fujishima N, Hirokawa M, Fujishima M, et al. Oligoclonal T cell expansion in blood but not in the thymus from a patient with thymoma-associated pure red cell aplasia. Haematologica. 2006;91:Ecr47.

PubMed  Google Scholar 

Facco M, Cabrelle A, Teramo A, et al. Sarcoidosis is a Th1/Th17 multisystem disorder. Thorax. 2011;66:144–50.

Article  PubMed  Google Scholar 

Esendagli D, Koksal D, Emri S. Recovery of pulmonary and skin lesions of sarcoidosis after thymectomy. Acta Clin Belg. 2016;71:441–3.

Article  PubMed  Google Scholar 

Broos CE, Koth LL, van Nimwegen M, et al. Increased T-helper 17.1 cells in sarcoidosis mediastinal lymph nodes. Eur Respir J. 2018;51:1701124.

Article  PubMed  Google Scholar 

Murata K, Asano M, Matsumoto A, et al. Induction of IFN-λ3 as an additional effect of nucleotide, not nucleoside, analogues: a new potential target for HBV infection. Gut. 2018;67:362–71.

Article  CAS  PubMed  Google Scholar